Matches in Nanopublications for { ?s ?p "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- NP537169.RAVWx5lLDN4axjANUP1j6Y_u9xvw1GxyEf03Y8Swb5HgA130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537169.RAVWx5lLDN4axjANUP1j6Y_u9xvw1GxyEf03Y8Swb5HgA130_provenance.
- NP349040.RApOMZrYFc91rP_-zmM7h2ggoH236ODvy0z9wIQSuIViU130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349040.RApOMZrYFc91rP_-zmM7h2ggoH236ODvy0z9wIQSuIViU130_provenance.
- NP198121.RAlkIBF4LiGCo3F6jyKnKi4gyiliJHTVN1Eak4kLMIszI130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198121.RAlkIBF4LiGCo3F6jyKnKi4gyiliJHTVN1Eak4kLMIszI130_provenance.
- NP815621.RAuQ_8qo7s48ubtcZnz5k1Bfj_MDtIb-sqNq_8ekHay5o130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815621.RAuQ_8qo7s48ubtcZnz5k1Bfj_MDtIb-sqNq_8ekHay5o130_provenance.
- NP706497.RAeNpHINsTFceLMAnTA3QodrJvta3yabkc28uahoHuqy0130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706497.RAeNpHINsTFceLMAnTA3QodrJvta3yabkc28uahoHuqy0130_provenance.
- NP453419.RA7g5AG7ofN1aKmGR7C1GYEIPl0m6bQr0uEEq8sriEZF0130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453419.RA7g5AG7ofN1aKmGR7C1GYEIPl0m6bQr0uEEq8sriEZF0130_provenance.
- NP522539.RAw023Q5rpg2cd_sL_HEJGaTvu6-GHXvNvaf8_qDhCRys130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522539.RAw023Q5rpg2cd_sL_HEJGaTvu6-GHXvNvaf8_qDhCRys130_provenance.
- NP260101.RAxRnGzxXNcPZApQr9I6x9xSsD122-j_QQZPdjCsogCqg130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260101.RAxRnGzxXNcPZApQr9I6x9xSsD122-j_QQZPdjCsogCqg130_provenance.
- NP430955.RA6OWzQ3RKoUURn40ecNCdKfyk8kh55xv8gFE6eLdI5dA130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430955.RA6OWzQ3RKoUURn40ecNCdKfyk8kh55xv8gFE6eLdI5dA130_provenance.
- NP531532.RAaJMrexycp0ajIvnihIRMStFQI9mWycOR3WnqMluDPn4130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531532.RAaJMrexycp0ajIvnihIRMStFQI9mWycOR3WnqMluDPn4130_provenance.
- NP729861.RA9utXEltaJpA8qHcIF6eRdxUHKYaAl2kzPB5CLurWG0o130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729861.RA9utXEltaJpA8qHcIF6eRdxUHKYaAl2kzPB5CLurWG0o130_provenance.
- NP539838.RAaOFUH3DO4tSBQSBrotrxpGlJTMMq2OQPRqWF3OAe6DU130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539838.RAaOFUH3DO4tSBQSBrotrxpGlJTMMq2OQPRqWF3OAe6DU130_provenance.
- NP661001.RASkOBayY28hR7Xff4WofHJiuURvaJaXSsw4hKMcVWhoE130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661001.RASkOBayY28hR7Xff4WofHJiuURvaJaXSsw4hKMcVWhoE130_provenance.
- NP833125.RAa4GD5KPyfdc0-QCkShvoGqMWRbQ5Ul0b5gaGWVcV-no130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833125.RAa4GD5KPyfdc0-QCkShvoGqMWRbQ5Ul0b5gaGWVcV-no130_provenance.
- NP1383298.RATJu2durdhUgaexs5XIxCJzwaord7btLsQatNenKikXE130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383298.RATJu2durdhUgaexs5XIxCJzwaord7btLsQatNenKikXE130_provenance.
- NP250790.RAucJooI5sOYQeaNTjrT3RqwJciaslYcIYOHg0EfLREVE130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250790.RAucJooI5sOYQeaNTjrT3RqwJciaslYcIYOHg0EfLREVE130_provenance.
- NP531579.RAB3mTODDyUvAwMJ3dUcM7HbAkmakkQ9eg0zcWvIJicZQ130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531579.RAB3mTODDyUvAwMJ3dUcM7HbAkmakkQ9eg0zcWvIJicZQ130_provenance.
- NP660982.RAp-vauKe3K50jvFlk22CJR_C1KGqUomEG7wOjAUJ0qgs130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660982.RAp-vauKe3K50jvFlk22CJR_C1KGqUomEG7wOjAUJ0qgs130_provenance.
- NP1383293.RAgw3e0mnTrS3b0OB9gsV1ozBU1Nk-8UR0qhpDdbaYK9o130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383293.RAgw3e0mnTrS3b0OB9gsV1ozBU1Nk-8UR0qhpDdbaYK9o130_provenance.
- NP1383296.RAtPE2JJ-MTxu6UUjjQg11uHXBPYLOuXs8DXsHTBwgnqs130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383296.RAtPE2JJ-MTxu6UUjjQg11uHXBPYLOuXs8DXsHTBwgnqs130_provenance.
- NP1383300.RAsSxDcjkU2iYp7dvTc6ZsQeJzOgybVjaI-Px2cRplUbE130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383300.RAsSxDcjkU2iYp7dvTc6ZsQeJzOgybVjaI-Px2cRplUbE130_provenance.
- NP1383304.RAgXMziP6Xa1t3RSFVFqvM9dcVsxMU1wCnxejIADBUpSE130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383304.RAgXMziP6Xa1t3RSFVFqvM9dcVsxMU1wCnxejIADBUpSE130_provenance.
- NP250126.RA4RDPL-vF7c7NUDxVXvA8z4G36B_LOFGgU9o1IlYGjUo130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250126.RA4RDPL-vF7c7NUDxVXvA8z4G36B_LOFGgU9o1IlYGjUo130_provenance.
- NP539793.RA0vlTYPjGPIVP2MAPoUCfqUDNmTFUtG8vlNWJyRABE2M130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539793.RA0vlTYPjGPIVP2MAPoUCfqUDNmTFUtG8vlNWJyRABE2M130_provenance.
- NP833160.RAN0SncLM3i9A5iURuFEu8bNVDlktfPr-f8x7TqZEemMA130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833160.RAN0SncLM3i9A5iURuFEu8bNVDlktfPr-f8x7TqZEemMA130_provenance.
- NP1383291.RAIMx9Pbz4PVDydpcBxb-SqoaQnk3jX4wfyUaHy8m5tnk130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383291.RAIMx9Pbz4PVDydpcBxb-SqoaQnk3jX4wfyUaHy8m5tnk130_provenance.
- NP1383297.RAJztU9HUm9vbHnYJ7BQLpfRUo88Y_NTCdJfHlQ01XtDc130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383297.RAJztU9HUm9vbHnYJ7BQLpfRUo88Y_NTCdJfHlQ01XtDc130_provenance.
- NP1383299.RAP177U7_MDbv2vtCumZo0L6TbtF2bj5TPIoW_zsNV0Mo130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383299.RAP177U7_MDbv2vtCumZo0L6TbtF2bj5TPIoW_zsNV0Mo130_provenance.
- NP1383305.RAHbGTgN7lImcPiugfuikXi7edle495ErGV3OHBaxDY3o130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383305.RAHbGTgN7lImcPiugfuikXi7edle495ErGV3OHBaxDY3o130_provenance.
- NP1383294.RA2UDCdkTmq1kOQ-C8yRs7s4zzQ-3UNKFvm6v6QYy3zIk130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383294.RA2UDCdkTmq1kOQ-C8yRs7s4zzQ-3UNKFvm6v6QYy3zIk130_provenance.
- NP1383302.RA-xEq_jErRuCFfn2ZOqL0bq0iQMNpcJq_HP7vBB71DEs130_assertion description "[Overexpression of a 110-kD protein (lung resistance-related protein [LRP]) may predict a poor response to chemotherapy in patients with acute myeloid leukemia (AML) and ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383302.RA-xEq_jErRuCFfn2ZOqL0bq0iQMNpcJq_HP7vBB71DEs130_provenance.